SCHEMBL21532745

SCHEMBL21532745

c1ccc(-c2nc(-c3ccccc3)n(-c3cccc4c5ccccc5n(-c5cccc(-n6c7ccccc7c7c8c(ccc76)oc6ccccc68)c5)c34)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.31
CA9 Q16790 2/20 0.31
MEN1 O00255 1/20 0.31
GAA P10253 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21532750 0.93 CA12 (0.31) CA12CA9MEN1GAAKMT2A
SCHEMBL21532504 0.92 CA12 (0.33) CA12CA9MEN1GAAKMT2A
SCHEMBL21532324 0.92 NPC1 (0.31) CA12CA9
SCHEMBL21532498 0.91 CA12 (0.31) CA12CA9MEN1GAAKMT2A
SCHEMBL21532435 0.90 CA12 (0.31) CA12CA9MEN1GAAKMT2A
SCHEMBL21532219 0.89 KDM4A (0.35) CA12CA9
SCHEMBL21532211 0.89 SMN1; SMN2 (0.33) CA12CA9SMN1; SMN2
SCHEMBL21532748 0.88 KMT2A (0.32) KMT2ASMN1; SMN2
SCHEMBL21532350 0.88 PTGER4 (0.34) CA12CA9
SCHEMBL21532489 0.87 KDM4E (0.35) MEN1GAAKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-10-12 US disclosed
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same CRY1, CCNT1, CCNA1 CA12 2336/4885CA9 2655/4885MEN1 55/4885
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, ARL1 CA12 2397/4885CA9 3038/4885MEN1 83/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.